Consensus ABIONYX Pharma Börse Stuttgart

Equities

609 FR0012616852

Delayed Börse Stuttgart Other stock markets 03:11:18 2024-06-14 am EDT			5-day change	1st Jan Change
1.382 ^EUR	+14.78%		+3.26%	-23.31%

Mar. 14	Abionyx Pharma: to benefit from a 1ME grant from Bpifrance	CF
Mar. 11	Abionyx: reduced net loss in 2023	CF

Evolution of the average Target Price on ABIONYX Pharma

Price target over the last 5 years

History of analyst recommendation changes

81cecba3319bd3.zTq0BVyLXIePSOT8y8-upDqVryWZBMRXie8xpcExbZI.uAztbzK8Pc7rHo-fgL3K9X3azGLfQ7Yiu6R19aVuBaGZd-FQauY93_gHpQ~532cba4be2ecc441c2fb6b35e8740a35

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.254 EUR

Average target price

10.5 EUR

Spread / Average Target

+737.32%

High Price Target

10.5 EUR

Spread / Highest target

+737.32%

Low Price Target

10.5 EUR

Spread / Lowest Target

+737.32%

Consensus detail

Consensus revision (last 18 months)

Ratings for ABIONYX Pharma

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar